Burden AD[Author] - Search Results

Year	Number of Results
1991	2
1992	4
1994	7
1996	3
1997	2
1998	2
1999	7
2000	2
2001	6
2002	3
2003	2
2004	3
2005	3
2006	2
2007	4
2008	5
2009	4
2010	7
2011	9
2012	10
2013	4
2014	5
2015	6
2016	5
2017	11
2018	9
2019	13
2020	10
2021	9

1

European consensus statement on phenotypes of pustular psoriasis.

Navarini AA, Burden AD, Capon F, Mrowietz U, Puig L, Köks S, Kingo K, Smith C, Barker JN; ERASPEN Network. Navarini AA, et al. Among authors: burden ad. J Eur Acad Dermatol Venereol. 2017 Nov;31(11):1792-1799. doi: 10.1111/jdv.14386. Epub 2017 Aug 29. J Eur Acad Dermatol Venereol. 2017. PMID: 28585342 Review.

2

Comparing the efficacy and tolerability of biologic therapies in psoriasis: an updated network meta-analysis.

Mahil SK, Ezejimofor MC, Exton LS, Manounah L, Burden AD, Coates LC, de Brito M, McGuire A, Murphy R, Owen CM, Parslew R, Woolf RT, Yiu ZZN, Uthman OA, Mohd Mustapa MF, Smith CH. Mahil SK, et al. Among authors: burden ad. Br J Dermatol. 2020 Oct;183(4):638-649. doi: 10.1111/bjd.19325. Epub 2020 Aug 9. Br J Dermatol. 2020. PMID: 32562551 Review.

3

British Association of Dermatologists guidelines for biologic therapy for psoriasis 2020: a rapid update.

Smith CH, Yiu ZZN, Bale T, Burden AD, Coates LC, Edwards W, MacMahon E, Mahil SK, McGuire A, Murphy R, Nelson-Piercy C, Owen CM, Parslew R, Uthman OA, Woolf RT, Manounah L, Ezejimofor MC, Exton LS, Mohd Mustapa MF; British Association of Dermatologists’ Clinical Standards Unit. Smith CH, et al. Among authors: burden ad. Br J Dermatol. 2020 Oct;183(4):628-637. doi: 10.1111/bjd.19039. Epub 2020 Jul 21. Br J Dermatol. 2020. PMID: 32189327 No abstract available.

4

Inhibition of the Interleukin-36 Pathway for the Treatment of Generalized Pustular Psoriasis.

Bachelez H, Choon SE, Marrakchi S, Burden AD, Tsai TF, Morita A, Turki H, Hall DB, Shear M, Baum P, Padula SJ, Thoma C. Bachelez H, et al. Among authors: burden ad. N Engl J Med. 2019 Mar 7;380(10):981-983. doi: 10.1056/NEJMc1811317. N Engl J Med. 2019. PMID: 30855749 Clinical Trial. No abstract available.

5

Quantitative Evaluation of Biologic Therapy Options for Psoriasis: A Systematic Review and Network Meta-Analysis.

Jabbar-Lopez ZK, Yiu ZZN, Ward V, Exton LS, Mohd Mustapa MF, Samarasekera E, Burden AD, Murphy R, Owen CM, Parslew R, Venning V, Warren RB, Smith CH. Jabbar-Lopez ZK, et al. Among authors: burden ad. J Invest Dermatol. 2017 Aug;137(8):1646-1654. doi: 10.1016/j.jid.2017.04.009. Epub 2017 Apr 27. J Invest Dermatol. 2017. PMID: 28457908 Free PMC article. Review.

6

Clinical and genetic differences between pustular psoriasis subtypes.

Twelves S, Mostafa A, Dand N, Burri E, Farkas K, Wilson R, Cooper HL, Irvine AD, Oon HH, Kingo K, Köks S, Mrowietz U, Puig L, Reynolds N, Tan ES, Tanew A, Torz K, Trattner H, Valentine M, Wahie S, Warren RB, Wright A, Bata-Csörgő Z, Szell M, Griffiths CEM, Burden AD, Choon SE, Smith CH, Barker JN, Navarini AA, Capon F. Twelves S, et al. Among authors: burden ad. J Allergy Clin Immunol. 2019 Mar;143(3):1021-1026. doi: 10.1016/j.jaci.2018.06.038. Epub 2018 Jul 21. J Allergy Clin Immunol. 2019. PMID: 30036598 Free PMC article.

7

IL-36 Promotes Systemic IFN-I Responses in Severe Forms of Psoriasis.

Catapano M, Vergnano M, Romano M, Mahil SK, Choon SE, Burden AD, Young HS, Carr IM, Lachmann HJ, Lombardi G, Smith CH, Ciccarelli FD, Barker JN, Capon F. Catapano M, et al. Among authors: burden ad. J Invest Dermatol. 2020 Apr;140(4):816-826.e3. doi: 10.1016/j.jid.2019.08.444. Epub 2019 Sep 17. J Invest Dermatol. 2020. PMID: 31539532 Free PMC article.

8

Secukinumab for moderate-to-severe palmoplantar pustular psoriasis: Results of the 2PRECISE study.

Mrowietz U, Bachelez H, Burden AD, Rissler M, Sieder C, Orsenigo R, Chaouche-Teyara K. Mrowietz U, et al. Among authors: burden ad. J Am Acad Dermatol. 2019 May;80(5):1344-1352. doi: 10.1016/j.jaad.2019.01.066. Epub 2019 Feb 1. J Am Acad Dermatol. 2019. PMID: 30716404 Free article. Clinical Trial.

9

British Association of Dermatologists guidelines for biologic therapy for psoriasis 2017.

Smith CH, Jabbar-Lopez ZK, Yiu ZZ, Bale T, Burden AD, Coates LC, Cruickshank M, Hadoke T, MacMahon E, Murphy R, Nelson-Piercy C, Owen CM, Parslew R, Peleva E, Pottinger E, Samarasekera EJ, Stoddart J, Strudwicke C, Venning VA, Warren RB, Exton LS, Mohd Mustapa MF. Smith CH, et al. Among authors: burden ad. Br J Dermatol. 2017 Sep;177(3):628-636. doi: 10.1111/bjd.15665. Br J Dermatol. 2017. PMID: 28513835 No abstract available.

10

Psoriasis treat to target: defining outcomes in psoriasis using data from a real-world, population-based cohort study (the British Association of Dermatologists Biologics and Immunomodulators Register, BADBIR).

Mahil SK, Wilson N, Dand N, Reynolds NJ, Griffiths CEM, Emsley R, Marsden A, Evans I, Warren RB, Stocken D, Barker JN, Burden AD, Smith CH; BADBIR study group and the PSORT consortium. Mahil SK, et al. Among authors: burden ad. Br J Dermatol. 2020 May;182(5):1158-1166. doi: 10.1111/bjd.18333. Epub 2019 Sep 10. Br J Dermatol. 2020. PMID: 31286471 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results